PharmaBio Corporation
PharmaBio Corporation
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) | Myopic Chorioretinal Atrophy | Active, not recruiting | Not applicable | 2026-09-29 | NCT05658237 | |
| Progression Suppression and Retinal Regression in VEGF-resistant AMD | Neovascular Age-related Macular Degeneration (AMD) | Recruiting | Not applicable | 2026-09-18 | NCT07005323 | |
| Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer | Skin Ulcer, Skin and Connective Tissue Diseases, skin disorder | Recruiting | Not applicable | 2025-06-11 | NCT07016438 |